Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1<i>H</i>-Pyrrolo[2,3<i>b</i>]pyridines Inhibitors of Trypanosome Proliferation

Neglected tropical diseases, such as human African trypanosomiasis (HAT), require novel treatments that can populate the clinical pipeline in the event of rising resistance and treatment recrudescence. Following a high-throughput screen of almost 42,000 human kinase inhibitor chemotypes, we identified a 2,4-disubstituted azaindole that had good antiparasitic activity, selectivity, and predicted brain exposure, but that failed to meet our criteria for advancement into an efficacy study. Following hit-to-lead optimization, we arrived at <b>18a,</b> which offered the best combination of potency, properties, and pharmacokinetic parameters, and, while not curative, this work leads to opportunities for continued optimization for HAT and cutaneous leishmaniasis.

Authors

Institutions

Publication Details

Journal
Journal of Medicinal Chemistry
Published
2025-09-20
DOI
https://doi.org/10.1021/acs.jmedchem.5c01217
Primary Topic
Synthesis and Biological Evaluation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines Inhibitors of Trypanosome Proliferation

Erica Penn, Kelly A. Bachovchin, Gloria Ceballos-Pérez, Guiomar Pérez‐Moreno et al.
Journal of Medicinal Chemistry
Synthesis and Biological Evaluation
article

Optimization of Physicochemical Properties and ADME for 2,4-Substituted 1H-Pyrrolo[2,3b]pyridines Inhibitors of Trypanosome Proliferation

Erica Penn, Kelly A. Bachovchin, Gloria Ceballos-Pérez, Guiomar Pérez‐Moreno, Baljinder Singh, Pilar Manzano-Chinchon, Dolores González‐Pacanowska, Richard J. Sciotti, Miguel Navarro, Lori Ferrins, Michael P. Pollastri, Maria Santos Martínez, Cristina Bosch‐Navarrete, Raquel García‐Hernández, Norma Roncal, Domingo I. Rojas-Barros, Rosario Díaz-González, Mitch Rivers, Robert F. Campbell, Luis M. Ruiz‐Pérez
article en

Abstract

Neglected tropical diseases, such as human African trypanosomiasis (HAT), require novel treatments that can populate the clinical pipeline in the event of rising resistance and treatment recrudescence. Following a high-throughput screen of almost 42,000 human kinase inhibitor chemotypes, we identified a 2,4-disubstituted azaindole that had good antiparasitic activity, selectivity, and predicted brain exposure, but that failed to meet our criteria for advancement into an efficacy study. Following hit-to-lead optimization, we arrived at <b>18a,</b> which offered the best combination of potency, properties, and pharmacokinetic parameters, and, while not curative, this work leads to opportunities for continued optimization for HAT and cutaneous leishmaniasis.

Journal of Medicinal ChemistryVol. 68(19)
Northeastern University (US), GlaxoSmithKline (France) (FR), Instituto de Parasitología y Biomedicina "López - Neyra" (ES), GMV Innovating Solutions (Spain) (ES), Universidad del Noreste (MX), Walter Reed Army Institute of Research (US)
Openalex Percentile: Top 81%
Synthesis and Biological Evaluation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.